Ensem Therapeutics
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $67M
Investors
- 5
About Ensem Therapeutics
Based in Massachusetts, US, and founded in 2021, Ensem Therapeutics, Inc. operates as a biotechnology research company that develops drugs intended to discover, develop, and commercialize transformative oncology therapies. In April 2022, Ensem Therapeutics, Inc., and CBC Group. Ensem Therapeutics, Inc. offers the Kinetic EnsembleTM platform that develops small molecule precision medicines for oncology, with expansion into genetic disorders and other disease areas. ENSEM integrates computational, artificial intelligence, and deep learning methodologies with experimental techniques to identify non-obvious binding pockets and accelerate structure-based drug design, with a focus on difficult-to-drug targets.
Who invested in Ensem Therapeutics
5 investors across 1 round
See all investors in Ensem Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 6, 2022
Amount
$67M
Investors
Questions about Ensem Therapeutics
Who invested in Ensem Therapeutics?
Ensem Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ensem Therapeutics raised?
Ensem Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ensem Therapeutics last raise money?
Ensem Therapeutics's most recent round on record is a Series A, in Apr 2022.
What does Ensem Therapeutics do?
Based in Massachusetts, US, and founded in 2021, Ensem Therapeutics, Inc.
Where is Ensem Therapeutics headquartered?
Ensem Therapeutics is headquartered in Medford, US.
Which VCs invest in companies like Ensem Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ensem Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ensem Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.